Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$13.2 - $17.76 $205,920 - $277,056
-15,600 Reduced 88.14%
2,100 $37,000
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $115,403 - $359,664
17,700 New
17,700 $332,000
Q2 2022

Aug 09, 2022

SELL
$4.66 - $13.96 $11,184 - $33,504
-2,400 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$11.89 - $24.68 $14,268 - $29,616
1,200 Added 100.0%
2,400 $30,000
Q4 2021

Feb 11, 2022

BUY
$24.14 - $35.18 $28,968 - $42,216
1,200 New
1,200 $29,000
Q3 2021

Nov 09, 2021

SELL
$27.38 - $42.21 $16,428 - $25,326
-600 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$26.34 - $46.62 $13,170 - $23,310
500 Added 500.0%
600 $17,000
Q1 2021

May 14, 2021

BUY
$45.96 - $68.02 $4,596 - $6,802
100 New
100 $5,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.